feed,title,long_url,short_url
Benzinga,"Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications",https://benzinga.com/general/biotech/21/04/20764860/illumina-kartos-therapeutics-team-up-to-develop-companion-diagnostic-for-tp53-haboring-cancer-ind,https://j.mp/3gzt40q
